Definitive Contract HR001121C0142
Award Date
6/15/21
Potential Completion Date
7/1/24
Potential Value
$978K
Federal Agency
Defense Advanced Research Projects Agency
Awardee
General Biologics Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02138, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
STTR Phase II
Primary Consortia Member
Not listed
Similar Awards
<p>This is a $225,000.00 Firm Fixed Price STTR Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to General Biologics Inc., a for-profit organization. The contract is for PATTERNED RESPONSIVE CELLULAR THERAPIES research and development, with work to be performed in Cambridge, MA. The contract is set aside for small businesses.</p>
This is a $225,000.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Technology Holding LLC, a small, for-profit limited liability company specializing in research and development services. The contract is part of DARPA's Small Business Innovation Research (SBIR) program and is for Phase I of an effort titled "AUTONOMOUS BIOMANUFACTORING AT REMOTE LOCATIONS". The contract has a total small business set-aside and supports the development of...
This is a $1,402,027.06 Firm Fixed Price STTR Phase II contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Ireprogram, LLC, a small business located in Ann Arbor, Michigan. The contract is for the development of a computational biology platform technology for cell conversion and differentiation. The contract was awarded under a total small business set-aside and is the result of a solicitation posted in August 2017. This STTR Phase II award follows a previously awarded...
<p>This is a $1,367,828.26 firm fixed-price STTR Phase II contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Beta Bionics, Inc., a small disadvantaged business. The contract was set aside for small businesses and has a performance period ending on July 22, 2022. It was awarded on June 23, 2020 under DARPA's 2018.C STTR solicitation. The contract is for research and development work, but the specific products or services being delivered are not provided.</p>
This is a Phase II Small Business Innovation Research (SBIR) contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Bifrost Biosystems Inc., a for-profit manufacturing organization. The $1,496,610.00 contract is for the development of a "Robust Operational Ultra-High Throughput Cell Lineage Tracking for Rapid Bioengineering and Pathogen Detection" platform. This platform is intended to empower bioengineering and biodetection capabilities by enabling...
This is a $583,435.00 firm-fixed-price definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Senti Biosciences, Inc. for a Biological Technologies Office study on programmable therapeutic cell circuit platforms. The contract has a completion date of January 31, 2018 and does not have a set-aside designation. As DARPA is the Defense Department's advanced research agency, this contract is likely part of their efforts to develop novel biotechnology capabilities for...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to B-Mogen Biotechnologies Inc. for the development of "NEXT GENERATION GENOME EDITING TOOLS." The contract is a firm-fixed-price definitive contract with a ceiling value of $149,431.43 and a period of performance ending on April 20, 2018. As an SBIR Phase I award, this contract is focused on the research and development of innovative technologies that...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Xilis Inc., a for-profit manufacturing organization. The contract is for the development of tissue-derived droplet micro-organospheres as models for high-throughput testing of pathogens, with a total potential value of $224,658.00. The contract has a firm fixed price pricing type and a completion date of August 31, 2021. The original solicitation was a Broad...
This is a $149,999 Small Business Technology Transfer (STTR) Phase I contract awarded by the Air Force Research Laboratory (AFRL) to Technology Holding LLC, a small, for-profit limited liability company. The contract is for the development of "Biomimetic Material Solutions for the Stabilization of Labile Reagents," which aims to leverage innovative biotechnology and materials science to address national security needs. Technology Holding LLC is the prime contractor on this...
This is a firm fixed-price Phase I Small Business Innovation Research (SBIR) contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Synvitrobio, Inc. (doing business as Tierra Biosciences), a minority-owned small business, in the amount of $149,999.91. The contract is for the development of "rapid, reliable and repeatable platforms for cell-free prototyping", which supports DARPA's work in biosystems research and materials innovations for the military. Synvitrobio...